Xylem Financial Statements (XYL)

Xylemsmart-lab.ru %   2023Q2 2023Q3 2023Q4 2023Q4 2024Q1   LTM ?
Report date 04.08.2023 31.10.2023 31.12.2023 28.02.2024 02.05.2024   02.05.2024
Currency USD USD USD USD USD   USD
Financial report URL  
Revenue, bln rub ? 1 722 2 076 2 118 2 119 0.000   6 313
Operating Income, bln rub 119.0 152.0 266.0 233.0 153.0   804.0
EBITDA, bln rub ? 246.0 152.0 266.0 370.0 153.0   941.0
Net profit, bln rub ? 92.0 152.0 266.0 266.0 153.0   837.0
OCF, bln rub ? 28.0 373.0 455.0 455.0   1 283
CAPEX, bln rub ? 54.0 74.0 94.0 94.0   262.0
FCF, bln rub ? -26.0 299.0 361.0 361.0   1 021
Dividend payout, bln rub 79.0 80.0 80.0 80.0   240.0
Ordinary share dividend yield, % 0.00% 0.00% 0.00% 0.00%   0.00%
Dividend payout ratio, % 85.9% 52.6% 30.1% 30.1% 0.00%   28.7%
OPEX, bln rub 504.0 552.0 1 852 526.0 0.000   2 930
Cost of production, bln rub 1 071 1 312 0.000 1 360 0.000   2 672
R&D, bln rub 58.0 61.0 0.000 60.0 0.000   121.0
Interest expenses, bln rub 12.0 14.0 0.000 21.0 0.000   35.0
Assets, bln rub 16 097 15 905 16 112 16 112 15 924   15 924
Net Assets, bln rub ? 9 899 9 930 10 166 10 166 10 195   10 195
Debt, bln rub 2 267 2 270 2 284 2 662 2 270   2 270
Cash, bln rub 708.0 705.0 1 019 1 019 947.0   947.0
Net debt, bln rub 1 559 1 565 1 265 1 643 1 323   1 323
Ordinary share price, rub 112.6 91.0 114.4 114.4   94.3
Number of ordinary shares, mln 205.5 240.9 242.5 241.5 241.8   241.8
Market cap, bln rub 23 148 21 926 27 732 27 618 0   22 802
EV, bln rub ? 24 707 23 491 28 997 29 261 1 323   24 125
Book value, bln rub -397 -258 2 579 50 232   232
EPS, rub ? 0.45 0.63 1.10 1.10 0.63   3.46
FCF/share, rub -0.13 1.24 1.49 1.49 0.00   4.22
BV/share, rub -1.93 -1.07 10.6 0.21 0.96   0.96
EBITDA margin, % ? 14.3% 7.32% 12.6% 17.5%   14.9%
Net margin, % ? 5.34% 7.32% 12.6% 12.6%   13.3%
FCF yield, % ? 1.54% 2.31% 2.04% 2.05%   4.48%
ROE, % ? 3.56% 4.95% 5.99% 5.99% 6.50%   8.21%
ROA, % ? 2.19% 3.09% 3.78% 3.78% 4.16%   5.26%
P/E ? 65.8 44.6 45.5 45.4 0.00   27.2
P/FCF 64.8 43.2 49.0 48.8 0.00   22.3
P/S ? 3.82 3.25 3.77 3.75 0.00   3.61
P/BV ? -58.3 -85.0 10.8 552.4 0.00   98.3
EV/EBITDA ? 30.1 27.0 33.4 30.1 1.44   25.6
Debt/EBITDA 1.90 1.80 1.46 1.69 1.44   1.41
R&D/CAPEX, % 107.4% 82.4% 0.00% 63.8%   46.2%
CAPEX/Revenue, % 3.14% 3.56% 4.44% 4.44%   4.15%
Xylem shareholders